Novo Nordisk is discontinuing one of its discounted insulin brands, Levemir, because of manufacturing issues, decreasing patient coverage, and the availability of alternative treatments.

Three U.S. Senators say they are "alarmed" Novo Nordisk discontinued U.S. sales of a popular insulin brand and are demanding ... to discontinue Levemir, a long-acting insulin, "failed to take ...

Nonprescription insulin ... long it works in your body. If you’re switching from newer formulations to OTC insulin, you may need to adjust your dosing schedule. For example, Sack says the short ...

Use of the long-acting insulin analogs glargine and detemir does not reduce the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus (T1DM), compared with the ...

For example, expenditures for just one long-acting insulin analogue, glargine, were the second largest of all Medicare expenditures in 2015. Insulin is one of the many essential drugs across all ...

In an awake individual, mild-to-moderate nocturnal hypoglycemia is easily corrected by ingesting a snack containing approximately 5 g of fast-acting carbohydrate ... the basal insulin, a bedtime ...

To mimic physiological insulin release, both long-acting and short-acting insulin preparations are needed. After decades of optimizations to develop longer-acting insulin preparations to reduce ...